{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:46:35Z","timestamp":1793025995875,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["443 JF-18- 017"],"award-info":[{"award-number":["443 JF-18- 017"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["RG9611"],"award-info":[{"award-number":["RG9611"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG051406"],"award-info":[{"award-number":["U01AG051406"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research Trust","doi-asserted-by":"publisher","award":["ARUK-PG2015-23"],"award-info":[{"award-number":["ARUK-PG2015-23"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.neurobiolaging.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:04:32Z","timestamp":1658354672000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Amyloid- \u03b2 and tau deposition influences cognitive and functional decline in Down syndrome"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-1642","authenticated-orcid":false,"given":"Monika","family":"Grigorova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.G.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Beresford-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young T.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D.","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-679X","authenticated-orcid":false,"given":"Jonathan P.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin I.","family":"Aigbirhio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Handen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Laymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-0251","authenticated-orcid":false,"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5385-008X","authenticated-orcid":false,"given":"Isabel C.H.","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid H.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.01.009","article-title":"The Down syndrome brain in the presence and absence of fibrillar \u03b2-amyloidosis","volume":"53","author":"Annus","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/014466507X230967","article-title":"Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities","volume":"47","author":"Ball","year":"2008","journal-title":"Br. J. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"Journal of Statistical Software"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09297040903146966","article-title":"NEPSY-II: A Developmental neuropsychological assessment","volume":"16","author":"Brooks","year":"2010","journal-title":"Child Neuropsychol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","article-title":"Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo","volume":"22","author":"Busche","year":"2019","journal-title":"Nature neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2022.07.003_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/01688638408401233","article-title":"Cued recall in amnesia","volume":"6","author":"Buschke","year":"1984","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2014.01.007","article-title":"Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease","volume":"64","author":"Chabrier","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0007","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","article-title":"Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition","volume":"14","author":"Cohen","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0008","first-page":"1","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease. Alzheimer's","volume":"12","author":"Colom-Cadena","year":"2020","journal-title":"Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0009","series-title":"Peabody Picture Vocabulary Test","author":"Dunn","year":"2007"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1352\/1944-7558-122.3.247","article-title":"Outcome measures for clinical trials in down syndrome","volume":"122","author":"Esbensen","year":"2017","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0011","first-page":"47","article-title":"Members of the National Task Group Section on Early Detection and Screening, \u2018National Task Group Early Detection Screen for Dementia: Manual","volume":"16","author":"Esralew","year":"2013","journal-title":"NADD Bull"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0012","first-page":"43","article-title":"The Dementia Questionnaire for People with Learning Disabilities","author":"Evenhuis","year":"2007","journal-title":"Neuropsychol. Assessments Dement. Down Syndr. Intellect. Disabil."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0013","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2353\/ajpath.2008.070829","article-title":"Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes","volume":"172","author":"Fein","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0014","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau with Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0015","article-title":"Role of Tau Deposition in Early Cognitive Decline in Down Syndrome. Alzheimer's Dement. Diagnosis","author":"Hartley","year":"2021","journal-title":"Assess. Dis. Monit"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0016","first-page":"1","article-title":"Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome","volume":"12","author":"Hartley","year":"2020","journal-title":"Alzheimer's Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0017","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to brain amyloid-\u03b2 in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2788.1989.tb01467.x","article-title":"Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults","volume":"33","author":"Haxby","year":"1989","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0020","doi-asserted-by":"crossref","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology","author":"Head","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau - A toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0022","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.1504081112","article-title":"Tau stabilizes microtubules by binding at the interface between tubulin heterodimers","volume":"112","author":"Kadavath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0023","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging Brain Amyloid in Alzheimer's Disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0024","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v075.i06","article-title":"Robustlmm: An R package for Robust estimation of linear Mixed-Effects models","volume":"75","author":"Koller","year":"2016","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0025","first-page":"1","article-title":"Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome. Alzheimer's Dement","volume":"12","author":"Krinsky-McHale","year":"2020","journal-title":"Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00414-3","article-title":"Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue","volume":"15","author":"Lemoine","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0027","first-page":"654","article-title":"Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report. Alzheimer's Dement","volume":"11","author":"Mak","year":"2019","journal-title":"Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcaa198","article-title":"Measuring cerebral perfusion with [11C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline","volume":"3","author":"Mak","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0029","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2019.02.018","article-title":"Delineating the topography of amyloid-associated cortical atrophy in Down's syndrome","volume":"80","author":"Mak","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2990.1986.tb00053.x","article-title":"The topography of plaques and tangles in Down's syndrome patients of different ages","volume":"12","author":"Mann","year":"1986","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0031","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: Their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0032","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","article-title":"Synergistic interaction between amyloid and tau predicts the progression to dementia","volume":"13","author":"Pascoal","year":"2017","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0034","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","article-title":"Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease","volume":"29","author":"Pickett","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-170390","article-title":"PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)","volume":"60","author":"Rafii","year":"2017","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0036","series-title":"Contemporary Intellectual Assessment: Theories, Tests, and Issues","first-page":"249","article-title":"No Title","author":"Roid","year":"2012"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0037","series-title":"Vineland adaptive behavior scales\u2013third edition (Vineland-3)","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2022.07.003_bib0039","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1037\/h0061266","article-title":"The Purdue Pegboard: norms and studies of reliability and validity","volume":"32","author":"Tiffin","year":"1948","journal-title":"Journal of Applied Psychology"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0040","first-page":"1","article-title":"Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline. Alzheimer's Dement","volume":"6","author":"Tudorascu","year":"2020","journal-title":"Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0041","first-page":"332","article-title":"The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimer's Dement","volume":"10","author":"Tudorascu","year":"2018","journal-title":"Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0042","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0043","author":"Wechsler","year":"2003"},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0044","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0045","doi-asserted-by":"crossref","first-page":"E3773","DOI":"10.1073\/pnas.1604519113","article-title":"Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling","volume":"113","author":"Yin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2022.07.003_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102740","article-title":"Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome","volume":"31","author":"Zammit","year":"2021","journal-title":"Neuroimage Clin"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:50:33Z","timestamp":1777528233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"alternative-id":["S0197458022001543"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.07.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid- \u03b2 and tau deposition influences cognitive and functional decline in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}